Vapi Pharmaceuticals Llp - Due diligence report

A 360° intelligence report on Vapi Pharmaceuticals Llp: trust score, financial health, credit view, compliance, directors, growth and distre…

2015-02-09 Pardi, Gujarat Active
Share
Connect MCP
VP Vapi Pharmaceuticals Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Vapi Pharmaceuticals Llp — 360° Intelligence Report

Generated from MCA filings & public records
78/100
Trust Score
Low Risk

Vapi Pharmaceuticals Llp is assessed as Low Risk with a Trust Score of 78/100. Vapi Pharmaceuticals Llp is an active limited liability partnership incorporated in 2015, operating in the Packaging sector. Reported revenue has declined across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 26 Sep 2026 from the latest processed filings. Vapi Pharmaceuticals Llp snapshot & full profile →

Financial Health › Good
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
78/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
100/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
55/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
70/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreModerate
55/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
55/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 70/100 Moderate
  • Profitable - internal accruals available.
  • Externally credit-rated (BB-).

Charges position: 5 open (45.71 cr) · 2 satisfied (17.13 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Icici Bank Limited6 48.0 cr
State Bank Of India1 48.0 cr
Compliance Score: 100/100 Low Risk
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 55/100
NameDIN / PANDesignationAppointedTenureDIN status
BANJUL ASHOK SHAH 01234567 Director 01/04/2018 6 yrs Approved
ASHOKKUMAR HARAKHCHAND SHAH 01234567 Director 01/04/2018 6 yrs Approved
RAJENDRAKUMAR KANTIBHAI PARMAR 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • RAJENDRAKUMAR KANTIBHAI PARMAR has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 55 · Distress 75
Growth signals & trust indicators
Profit expanded 38% year-on-year.
Net margin improved to 1.42.
Operating for 11+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Revenue declined year-on-year.
5 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence86/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment73/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 5 open charge(s) of 45.71 cr already registered.
  • Compliance record supports lending.
Investor view61/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 15 events
31 May 2025
Charge created
Icici Bank Limited - 17.50 cr
31 Mar 2025
Last AGM held
Annual general meeting
Latest balance sheet
Filed with ROC
11 Mar 2025
Director appointed
RAJENDRAKUMAR KANTIBHAI PARMAR (Designated Partner)
03 Jan 2024
Charge satisfied
Icici Bank Limited
21 Dec 2023
Charge created
Icici Bank Limited - 11.34 cr
Charge created
Icici Bank Limited - 87.00 Lakh
23 Nov 2022
Director ceased
ASHOKKUMAR HARAKHCHAND SHAH
15 Nov 2022
Director ceased
PRIYESH PRAKASH SHAH
28 Dec 2020
Charge created
Icici Bank Limited - 3.00 cr
25 Jun 2020
Charge created
Icici Bank Limited - 2.28 cr
18 Mar 2019
Charge satisfied
State Bank Of India
08 Mar 2019
Charge created
Icici Bank Limited - 13.00 cr
19 Nov 2018
Director ceased
SIMONA BANJUL SHAH
10 Oct 2016
Charge created
State Bank Of India - 14.85 cr
10

Key Observations

Auto-generated from the data above
Revenue declined 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Compliance record is strong - status, filings and flags are clean.
3 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Carries an external credit rating of BB- from Icra.
EPFO-registered employer - verifiable payroll history exists.
11

Peers & Related Companies

Full peer comparison →
Peer companies will appear here as our matching engine processes this industry.
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Vapi Pharmaceuticals Llp before audits and certifications: compliance score 100/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Vapi Pharmaceuticals Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 70/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 55/100, margin trends, ownership structure and peer set for Vapi Pharmaceuticals Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 78/100, distress signals and MSME payment-delay disclosures - know whether Vapi Pharmaceuticals Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Vapi Pharmaceuticals Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Vapi Pharmaceuticals Llp an active company?

Vapi Pharmaceuticals Llp has MCA status “Active” with a compliance score of 100/100 (Low Risk).

Is Vapi Pharmaceuticals Llp financially healthy?

Vapi Pharmaceuticals Llp has a Financial Health Score of 55/100 (Moderate) based on its filed financial statements.

Should I do business with Vapi Pharmaceuticals Llp?

Its overall Trust Score is 78/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Vapi Pharmaceuticals Llp?

See the directors and ownership sections above for board and shareholding detail. 3 active director(s) are on record.

Does Vapi Pharmaceuticals Llp have loans or charges against its assets?

5 open charge(s) are registered against its assets, and 2 earlier charge(s) stand satisfied.

Is Vapi Pharmaceuticals Llp up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 100/100 (Low Risk).

Is it risky to lend to Vapi Pharmaceuticals Llp?

Its Credit Risk Score is 70/100 (Moderate). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.